February 26, 2026— INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early-stage anti-infective innovation, today announced a collaboration with the Cystic Fibrosis Foundation to advance research, innovation, and solutions [...]
More news
INCATE kicked off the AMR week in Basel with the INCATE Networking Event on February [...]
Our colleague Helmut Kessmann has decided his time has come to retire and embark on new [...]
The INCATE Selection Committee selected the new 4 ventures for Stage I support. Meet the [...]
The AMR Conference 2025 has reached another milestone as the finalists for this year’s Poster [...]
A&J Science, an innovative biotech company based in South Korea and dedicated to addressing AMR, [...]
After receiving over 40 impressive applications and conducting a rigorous selection process, we are ready [...]
December 16, 2024 – INCATE (the INCubator for Antibacterial Therapies in Europe), is delighted to [...]
December 16, 2024 – INCATE (INCubator for Antibacterial Therapies in Europe) is pleased to announce [...]
